{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:42:37Z","timestamp":1775065357490,"version":"3.50.1"},"reference-count":78,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"Centre of Chemistry of University of Minho (CQUM)","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"Centro de F\u00edsica das Universidades do Minho e do Porto (CF-UM-UP)","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"Centro de Engenharia Biol\u00f3gica da Universidade do Minho (CEB-UM)","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"LABBELS\u2014Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"FEDER\/FCT","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"FEDER\/FCT","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"FEDER\/FCT","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"FEDER\/FCT","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"FEDER\/FCT","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"FEDER\/FCT","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"FEDER\/FCT","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"Rede Nacional de RMN","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"Rede Nacional de RMN","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"Rede Nacional de RMN","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"Rede Nacional de RMN","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"Rede Nacional de RMN","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"Rede Nacional de RMN","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"Rede Nacional de RMN","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"FCT","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"FCT","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"FCT","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"FCT","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"FCT","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"FCT","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"FCT","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["UID\/00686"],"award-info":[{"award-number":["UID\/00686"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["UID\/04650"],"award-info":[{"award-number":["UID\/04650"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["UID\/04469"],"award-info":[{"award-number":["UID\/04469"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["LA\/P\/0029\/2020"],"award-info":[{"award-number":["LA\/P\/0029\/2020"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["PTDC\/MED-ONC\/31354\/2017"],"award-info":[{"award-number":["PTDC\/MED-ONC\/31354\/2017"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["PINFRA\/22161\/2016"],"award-info":[{"award-number":["PINFRA\/22161\/2016"]}]},{"name":"FSE (Fundo Social Europeu) through \u201cPrograma Operacional Regional Norte\u201d","award":["2020.04975.BD"],"award-info":[{"award-number":["2020.04975.BD"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Cancer is one of the deadliest diseases worldwide. Despite the existing treatments, the adverse side effects and the increasing drug resistance to the current therapies lead to a reduced quality of life for patients and poor prognosis. The pyrimido[5,4-d]pyrimidine compound (PP) was identified as a promising new anticancer drug due to its potent activity against colorectal and triple-negative breast cancers; however it showed poor aqueous solubility and safety profile. This study aimed the synthesis of compound PP, its encapsulation in liposomal formulations based on phosphatidylcholines (PC), the characterization of liposomal formulations and its biological evaluation. Methods: A new synthesis method for PP was developed. The compound was incorporated into different liposomal formulations. The hydrodynamic size, polydispersity, and zeta potential of loaded and non-loaded formulations were measured by DLS. The cytotoxic effects of compound PP, placebo nanoformulations, and PP-loaded nanoformulations were assessed in colorectal (HCT 116) and triple-negative breast cancer (MDA-MB-231) cell lines, as well as in non-tumor BJ-5ta cells. Results: The PP compound was efficiently synthesized. The PP-loaded liposomal formulations exhibit sizes below 150 nm, low polydispersity, and long-time stability upon storage at 4 \u00b0C. The antitumor compound was encapsulated with excellent efficiency, and sustained release profiles were obtained. The PP compound showed high activity against HCT 116 (IC50 = 2.04 \u00b1 0.45 \u00b5M) and MDA-MB-231 (IC50 = 5.24 \u00b1 0.24 \u00b5M) cell lines. DPPC-containing formulations were effective against cancer cells, but showed toxicity comparable to free PP in BJ-5ta normal cells. Conversely, PP-EggPC-Chol-L formulation displayed strong anticancer activity with residual toxicity to normal cells. Conclusions: The PP-loaded liposomal formulation, composed of 70% PC from egg yolk (EggPC) and 30% cholesterol (Chol), designated as PP-EggPC-Chol-L, was the most promising formulation, showing effective anticancer activity in both cancer cell lines and a significant improvement in the safety profile which is of utmost importance to progress to the next phase of drug development.<\/jats:p>","DOI":"10.3390\/ph18081210","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T14:24:28Z","timestamp":1755267868000},"page":"1210","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liposomal Formulations for Efficient Delivery of a Novel, Highly Potent Pyrimidine-Based Anticancer Drug"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4086-0975","authenticated-orcid":false,"given":"Sofia","family":"Teixeira","sequence":"first","affiliation":[{"name":"Chemistry Centre of University of Minho (CQ-UM), Campus de Gualtar, 4710-057 Braga, Portugal"},{"name":"Physics Centre of Minho and Porto Universities (CF-UM-UP), LaPMET (Laboratory of Physics for Materials and Emergent Technologies), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0937-4047","authenticated-orcid":false,"given":"D\u00e9bora","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal"},{"name":"LABBELS\u2014Associated Laboratory, Campus de Azur\u00e9m, 4800-058 Guimar\u00e3es, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-1713","authenticated-orcid":false,"given":"Ana Rita O.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Physics Centre of Minho and Porto Universities (CF-UM-UP), LaPMET (Laboratory of Physics for Materials and Emergent Technologies), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9265-0630","authenticated-orcid":false,"given":"Ligia R.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal"},{"name":"LABBELS\u2014Associated Laboratory, Campus de Azur\u00e9m, 4800-058 Guimar\u00e3es, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-6081","authenticated-orcid":false,"given":"Elisabete M. S.","family":"Castanheira","sequence":"additional","affiliation":[{"name":"Physics Centre of Minho and Porto Universities (CF-UM-UP), LaPMET (Laboratory of Physics for Materials and Emergent Technologies), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-0362","authenticated-orcid":false,"given":"Maria Alice","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Chemistry Centre of University of Minho (CQ-UM), Campus de Gualtar, 4710-057 Braga, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Masci, D., Naro, C., Puxeddu, M., Urbani, A., Sette, C., La Regina, G., and Silvestri, R. (2023). Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment. Molecules, 28.","DOI":"10.3390\/molecules28227513"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hossain, M.S., Karuniawati, H., Jairoun, A.A., Urbi, Z., Ooi, D.J., John, A., Lim, Y.C., Kibria, K.M.K., Mohiuddin, A.K.M., and Ming, L.C. (2022). Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers, 14.","DOI":"10.3390\/cancers14071732"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Iorga, C., Iorga, C.R., Grigorescu, A., Bengulescu, I., Constantin, T., and Strambu, V. (2024). Synchronous Breast and Colorectal Malignant Tumors\u2014A Systematic Review. Life, 14.","DOI":"10.3389\/fendo.2023.1191914"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Padma, V.V. (2015). An overview of targeted cancer therapy. BioMedicine, 5.","DOI":"10.7603\/s40681-015-0019-4"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhan, Z., Yin, X., Fu, S., and Deng, X. (2021). Targeted Therapeutic Strategies for Triple-Negative Breast Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.731535"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.12.066","article-title":"Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases","volume":"378","author":"Zhao","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Balboni, A., Ailuno, G., Baldassari, S., Drava, G., Petretto, A., Grinovero, N., Cavalleri, O., Angeli, E., Lagomarsino, A., and Canepa, P. (2024). Human glioblastoma-derived cell membrane nanovesicles: A novel, cell-specific strategy for boron neutron capture therapy of brain tumors. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-69696-7"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jconrel.2024.12.010","article-title":"Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer","volume":"378","author":"Meng","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Haque, M., Shakil, M.S., and Mahmud, K.M. (2023). The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment. Cancers, 15.","DOI":"10.3390\/cancers15061892"},{"key":"ref_12","unstructured":"(2025, January 13). Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer with and Without Intra-Operative RT: A Window of Opportunity Study, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02977468."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"48625","DOI":"10.1021\/acsomega.3c07345","article-title":"Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges","volume":"8","author":"Rahman","year":"2023","journal-title":"ACS Omega"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1039\/D2CC06212G","article-title":"Colorectal cancer therapy mediated by nanomedicines","volume":"59","author":"Zhang","year":"2023","journal-title":"Chem. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Badawi, W.A., Samir, M., Fathy, H.M., Okda, T.M., Noureldin, M.H., Atwa, G.M.K., and AboulWafa, O.M. (2023). Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Bioorg. Chem., 138.","DOI":"10.1016\/j.bioorg.2023.106610"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ben Hassen, M., Msalbi, D., Jismy, B., Elghali, F., Aifa, S., Allouchi, H., Abarbri, M., and Chabchoub, F. (2023). Three Component One-Pot Synthesis and Antiproliferative Activity of New [1,2,4]Triazolo[4,3-a]pyrimidines. Molecules, 28.","DOI":"10.3390\/molecules28093917"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/2159-8290.CD-24-0306","article-title":"Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers","volume":"15","author":"Wilding","year":"2025","journal-title":"Cancer Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mc.21938","article-title":"EGFR Inhibitor BIBU Induces Apoptosis and Defective Autophagy in Glioma Cells","volume":"982","author":"Ghildiyal","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1124\/jpet.104.069138","article-title":"Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives","volume":"311","author":"Solca","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/jm101493z","article-title":"Nucleoside Transport Inhibitors: Structure\u2212Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of \u03b1 1-Acid Glycoprotein","volume":"54","author":"Saravanan","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1039\/C5SC02983J","article-title":"Access to a new class of synthetic building blocks via trifluoromethoxylation of pyridines and pyrimidines","volume":"7","author":"Feng","year":"2016","journal-title":"Chem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1039\/C7MD00381A","article-title":"A systematic analysis of atomic protein\u2013ligand interactions in the PDB","volume":"8","author":"Schapira","year":"2017","journal-title":"Medchemcomm"},{"key":"ref_23","unstructured":"Fernandes, J.F.S. (2013). Evaluation of the Anticancer Potential of New Nitrogen Heterocycles in Human Colon Cancer Cells. [Master\u2019s Thesis, University of Minho]. Available online: https:\/\/core.ac.uk\/download\/pdf\/55628911.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Teixeira, S., Carvalho, M.A., and Castanheira, E.M.S. (2022). Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020486"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867325666181101110050","article-title":"Nanocarriers: A Successful Tool to Increase Solubility, Stability and Optimise Bioefficacy of Natural Constituents","volume":"26","author":"Bilia","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, T., Chen, H., Jiang, Y., Yan, Q., Zheng, S., and Wu, M. (2022). Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070881"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lee, M.-K. (2020). Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030264"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., and Elkordy, A. (2018). Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules, 23.","DOI":"10.3390\/molecules23040907"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of various types of liposomes in drug delivery systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin Nanoparticle-Based Drug Delivery Systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N., and Khan, W. (2017). Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020012"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/ja808541r","article-title":"Thermodynamic Analysis of the Effect of Cholesterol on Dipalmitoylphosphatidylcholine Lipid Membranes","volume":"131","author":"Bennett","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1515\/chem-2019-0070","article-title":"Characteristics of liposomes derived from egg yolk","volume":"17","author":"Kondratowicz","year":"2019","journal-title":"Open Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S0040-4020(01)00124-7","article-title":"Peptaibolin: Synthesis, 3D-structure, and membrane modifying properties of the natural antibiotic and selected analogues","volume":"57","author":"Crisma","year":"2001","journal-title":"Tetrahedron"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30835","DOI":"10.1039\/C9RA05687D","article-title":"Bicyclic 6 + 6 systems: The chemistry of pyrimido[4,5-d]pyrimidines and pyrimido[5,4-d]pyrimidines","volume":"9","author":"Monier","year":"2019","journal-title":"RSC Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2012.08.020","article-title":"Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer","volume":"57","author":"Virgilio","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1021\/jm040772w","article-title":"Resistance-modifying agents. 11. Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to \u03b1 1-acid glycoprotein","volume":"47","author":"Curtin","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/jm960879m","article-title":"Tyrosine Kinase Inhibitors. 12. Synthesis and Structure\u2212Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor","volume":"40","author":"Rewcastle","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1021\/jo00410a027","article-title":"Chemistry of diaminomaleonitrile. 3. Reaction with isocyanate: A novel pyrimidine synthesis","volume":"43","author":"Ohtsuka","year":"1978","journal-title":"J. Org. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tet.2018.12.057","article-title":"Design, two-directional synthesis, DFT study of new pyrimido[5,4-d]pyrimidine-2,8-dione derivatives","volume":"75","author":"Mahmoodi","year":"2019","journal-title":"Tetrahedron"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/jm00140a006","article-title":"Synthesis and antiviral activity of certain 9-.beta.-D-ribofuranosylpurine-6-carboxamides","volume":"24","author":"Westover","year":"1981","journal-title":"J. Med. Chem."},{"key":"ref_43","first-page":"108","article-title":"Controlled stepwise conversion of 2,4,6,8-tetrachloropyrimido-[5,4-d]pyrimidine into 2,4,6,8-tetrasubstituted pyrimido[5,4-d]pyrimidines","volume":"2","author":"Northen","year":"2002","journal-title":"J. Chem. Soc. Perkin Trans. 1"},{"key":"ref_44","unstructured":"Thyagarajan, B.S. (1968). Mechanisms of Molecular Migration, Interscience Publishers."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1002\/ejoc.200900216","article-title":"A Mild Approach to the Synthesis of 4-Amino-8-(arylamino)pyrimido[5,4-d]pyrimidine 3-Oxides","volume":"2009","author":"Ribeiro","year":"2009","journal-title":"Eur. J. Org. Chem."},{"key":"ref_46","first-page":"343","article-title":"6-Carbohydrazonamidepurines: Convenient Precursors for 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines","volume":"25","author":"Rocha","year":"2014","journal-title":"Synlett"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e202300251","DOI":"10.1002\/ajoc.202300251","article-title":"A Tandem Reaction in the Synthesis of New 4,8-Disubstituted-pyrimido[5,4-d]pyrimidine Derivatives","volume":"12","author":"Rocha","year":"2023","journal-title":"Asian J. Org. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jhet.5570340306","article-title":"Synthesis of 6-cyanopurines and the isolation and X-ray structure of novel 2H-pyrroles","volume":"34","author":"Alves","year":"1997","journal-title":"J. Heterocycl. Chem."},{"key":"ref_49","first-page":"2532","article-title":"Facile synthesis of 6-cyano-9-substituted-9H-purines and their ring expansion to 8-(arylamino)-4-imino-3-methylpyrimidino[5,4-d]pyrimidines","volume":"1","author":"Booth","year":"2001","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ejoc.200600883","article-title":"An Efficient Synthesis of 7,8-Dihydropyrimido[5,4-d]pyrimidines","volume":"2007","author":"Carvalho","year":"2007","journal-title":"Eur. J. Org. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.ejmech.2010.03.047","article-title":"Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of Antimycobacterium tuberculosis agents","volume":"45","author":"Bacelar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_52","first-page":"81","article-title":"A review on phospholipids and their main applications in drug delivery systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1021\/bi00083a025","article-title":"Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies","volume":"32","author":"Vincent","year":"1993","journal-title":"Biochemistry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current Trends in The Use of Liposomes for Tumor Targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Baranov, M.V., Kumar, M., Sacanna, S., Thutupalli, S., and van den Bogaart, G. (2021). Modulation of Immune Responses by Particle Size and Shape. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.607945"},{"key":"ref_57","first-page":"444","article-title":"Size, shape, charge and \u201cstealthy\u201d surface: Carrier properties affect the drug circulation time in vivo","volume":"16","author":"Di","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1016344523988","article-title":"Stability of Liposomes on Storage: Freeze Dried, Frozen or as an Aqueous Dispersion","volume":"1","author":"Crommelin","year":"1984","journal-title":"Pharm. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","article-title":"Liposome: Composition, characterisation, preparation, and recent innovation in clinical applications","volume":"27","author":"Ahmed","year":"2019","journal-title":"J. Drug Target."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Doskocz, J., Da\u0142ek, P., Fory\u015b, A., Trzebicka, B., Przyby\u0142o, M., Mesarec, L., Igli\u010d, A., and Langner, M. (2020). The effect of lipid phase on liposome stability upon exposure to the mechanical stress. Biochim. Biophys. Acta (BBA) Biomembr., 1862.","DOI":"10.1016\/j.bbamem.2020.183361"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1021\/ja1002185","article-title":"Nanomechanics of Lipid Bilayers: Heads or Tails?","volume":"132","author":"Oncins","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"104807","DOI":"10.1016\/j.chemphyslip.2019.104807","article-title":"Contribution of headgroup and chain length of glycerophospholipids to thermal stability and permeability of liposomes loaded with calcein","volume":"225","author":"Prislan","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/ma00015a038","article-title":"Chain-length dependence of the glass transition temperature","volume":"24","author":"Sanayei","year":"1991","journal-title":"Macromolecules"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: Structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/j.xphs.2020.07.015","article-title":"Freeze-Drying of Pharmaceutical and Nutraceutical Nanoparticles: The Effects of Formulation and Technique Parameters on Nanoparticles Characteristics","volume":"109","author":"Mohammady","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","article-title":"On the use of the Weibull function for the discernment of drug release mechanisms","volume":"309","author":"Papadopoulou","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_68","unstructured":"(2024, December 01). World Health Organization\u2014Cancer. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gbian, D.L., and Omri, A. (2022). Lipid-Based Drug Delivery Systems for Diseases Managements. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092137"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/bi00499a015","article-title":"Modulation of Phospholipid Acyl Chain Order by Cholesterol. A Solid-State 2H Nuclear Magnetic Resonance Study","volume":"29","author":"Sankaram","year":"1990","journal-title":"Biochemistry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0005-2736(03)00016-6","article-title":"Role of cholesterol in lipid raft formation: Lessons from lipid model systems","volume":"1610","author":"Silvius","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamem.2008.08.022","article-title":"Ordering effects of cholesterol and its analogues","volume":"1788","author":"Vattulainen","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0009-3084(89)90049-2","article-title":"Membrane \u201cfluidity\u201d as detected by diphenylhexatriene probes","volume":"50","author":"Lentz","year":"1989","journal-title":"Chem. Phys. Lipids"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/jacsau.1c00493","article-title":"Cholesterol\u2019s Condensing Effect: Unpacking a Century-Old Mystery","volume":"2","author":"Regen","year":"2022","journal-title":"JACS Au"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.apsb.2019.02.010","article-title":"Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect","volume":"9","author":"Wu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_76","unstructured":"Conn, P.M. (2013). Chapter 40\u2014Animal Models for Studying Prevention and Treatment of Breast Cancer. Animal Models for the Study of Human Disease, Academic Press."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/08982100903347923","article-title":"Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation","volume":"20","author":"Diab","year":"2010","journal-title":"J. Liposome Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"14375","DOI":"10.1039\/D2NJ01893D","article-title":"Synthesis, computational and nanoencapsulation studies on eugenol-derived insecticides","volume":"46","author":"Coelho","year":"2022","journal-title":"New J. Chem."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/8\/1210\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:28:37Z","timestamp":1760034517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/8\/1210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":78,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ph18081210"],"URL":"https:\/\/doi.org\/10.3390\/ph18081210","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}